newsfilter
← Latest News
GlobeNewswire·

Synlogic Announces Second Quarter 2022 Conference Call and Webcast

CAMBRIDGE, Mass., July 28, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (NASDAQ:SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its proprietary approach to synthetic biology, today announc